Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.

Abstract:

BACKGROUND:p53 (encoded by TP53) is involved in DNA damage repair, cell cycle regulation, apoptosis, aging and cellular senescence. TP53 is mutated in around 50% of human cancers. Nevertheless, the consequences of p53 inactivation in colon cancer outcome remain unclear. Recently, a new role of p53 together with CSNK1A1 in colon cancer invasiveness has been described in mice. METHODS:By combining data on different levels of p53 inactivation, we aimed to predict p53 functionality and to determine its effects on colon cancer outcome. Moreover, survival effects of CSNK1A1 together with p53 were also studied.Eighty-three formalin fixed paraffin embedded colon tumors were enriched for tumor cells using flow sorting, the extracted DNA was used in a custom SNP array to determine chr17p13-11 allelic state; p53 immunostaining, TP53 exons 5, 6, 7 and 8 mutations were determined in combination with mRNA expression analysis on frozen tissue. RESULTS:Patients with a predicted functional p53 had a better prognosis than patients with non functional p53 (Log Rank p=0.009). Expression of CSNK1A1 modified p53 survival effects. Patients with low CSNK1A1 expression and non-functional p53 had a very poor survival both in the univariate (Log Rank p<0.001) and in the multivariate survival analysis (HR=4.74 95% CI 1.45 - 15.3 p=0.009). CONCLUSION:The combination of mutational, genomic, protein and downstream transcriptional activity data predicted p53 functionality which is shown to have a prognostic effect on colon cancer patients. This effect was specifically modified by CSKN1A1 expression.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Sarasqueta AF,Forte G,Corver WE,de Miranda NF,Ruano D,van Eijk R,Oosting J,Tollenaar RA,van Wezel T,Morreau H

doi

10.1186/1471-2407-13-277

subject

Has Abstract

pub_date

2013-06-05 00:00:00

pages

277

issn

1471-2407

pii

1471-2407-13-277

journal_volume

13

pub_type

杂志文章
  • Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).

    abstract:BACKGROUND:Although modest improvements in the survival of patients with non-small cell lung cancer (NSCLC) can be achieved with cisplatin-based chemotherapy (CT), its value is disputed in the geriatric setting. In this study, we evaluate the feasibility of vinorelbine/cisplatin CT for elderly NSCLC patients. METHODS:...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-4-69

    authors: Pereira JR,Martins SJ,Nikaedo SM,Ikari FK

    更新日期:2004-09-29 00:00:00

  • Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.

    abstract:BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC are the same, because there exist intra-tumoral heterogeneity between PDAC, which poses a great challenge to personalized treatments for PDAC. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-4546-8

    authors: Zhao L,Zhao H,Yan H

    更新日期:2018-05-29 00:00:00

  • Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.

    abstract:BACKGROUND:Computational intelligence methods, including non-linear classification algorithms, can be used in medical research and practice as a decision making tool. This study aimed to evaluate the usefulness of artificial intelligence models for 5-year overall survival prediction in patients with cervical cancer tre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3806-3

    authors: Obrzut B,Kusy M,Semczuk A,Obrzut M,Kluska J

    更新日期:2017-12-12 00:00:00

  • Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016.

    abstract:BACKGROUND:Oncotype DX® (ODX) is used to assess risk of disease recurrence in hormone receptor positive, HER2-negative breast cancer and to guide decisions regarding adjuvant chemotherapy. Little is known about how physician factors impact treatment decisions. The purpose of this study was to examine patient and physic...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07355-6

    authors: Schwedhelm TM,Rees JR,Onega T,Zipkin RJ,Schaefer A,Celaya MO,Moen EL

    更新日期:2020-09-03 00:00:00

  • Sensitive HPV detection in oropharyngeal cancers.

    abstract:BACKGROUND:Human papillomaviruses (HPV) are the aetiological agents of certain benign and malignant tumours of skin and mucosae; the most important of which is cervical cancer. Also, the incidence of ano-genital warts, HPV-anal cancer and oropharyngeal cancers are rising. To help ascertain a useful PCR detection protoc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-440

    authors: Winder DM,Ball SL,Vaughan K,Hanna N,Woo YL,Fränzer JT,Sterling JC,Stanley MA,Sudhoff H,Goon PK

    更新日期:2009-12-15 00:00:00

  • Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.

    abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a type of head-neck cancer with a distinguishable geographic and racial distribution worldwide. Increasing evidence supports that the accumulation of additional genetic and epigenetic abnormalities is important in driving the NPC tumorigenic process. In this study, we aim to...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2714-2

    authors: Huang PY,Zeng TT,Ban X,Li MQ,Zhang BZ,Zhu YH,Hua WF,Mai HQ,Zhang L,Guan XY,Li Y

    更新日期:2016-08-22 00:00:00

  • Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.

    abstract:BACKGROUND:To compare the survival outcomes and acute toxicities of concurrent chemoradiotherapy (CCRT), induction chemotherapy (IC) plus radiotherapy (RT), and IC plus CCRT in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated using intensity-modulated radiotherapy (IMRT). METHODS:Patients w...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1768-x

    authors: Li WF,Li YQ,Chen L,Zhang Y,Guo R,Zhang F,Peng H,Sun Y,Ma J

    更新日期:2015-10-27 00:00:00

  • Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.

    abstract:BACKGROUND:Kaiso has been identified as a new member of the POZ-zinc finger family of transcription factors that are implicated in development and cancer. Although controversy still exists, Kaiso is supposed to be involved in human cancer. However, there is limited information regarding the clinical significance of cyt...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-178

    authors: Dai SD,Wang Y,Miao Y,Zhao Y,Zhang Y,Jiang GY,Zhang PX,Yang ZQ,Wang EH

    更新日期:2009-06-09 00:00:00

  • Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

    abstract:BACKGROUND:FOXM1 regulates expression of cell cycle related genes that are essential for progression into DNA replication and mitosis. Consistent with its role in proliferation, elevated expression of FOXM1 has been reported in a variety of human tumour entities. FOXM1 is a gene of interest because recently chemical in...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-42

    authors: Bektas N,Haaf At,Veeck J,Wild PJ,Lüscher-Firzlaff J,Hartmann A,Knüchel R,Dahl E

    更新日期:2008-02-06 00:00:00

  • Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.

    abstract:BACKGROUND:The objective of this systematic review and meta-analysis was to determine the prognostic value of total tumor-infiltrating lymphocytes (TILs) and subtypes of TILs (CD4+, CD8+, and FOXP3+) in triple-negative breast cancer (TNBC). METHODS:A systematic search of the MEDLINE, EMBASE, and Web of Science databas...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-020-6668-z

    authors: Gao G,Wang Z,Qu X,Zhang Z

    更新日期:2020-03-04 00:00:00

  • Extramammary Paget's disease with the appearance of a nodule: a case report.

    abstract:BACKGROUND:Extramammary Paget's disease (EMPD) remains a rare condition with only a limited number of cases reported in the literature. EMPD is mainly composed of intraepidermal Paget cells, and possesses variable clinical behaviors and histological appearances, leading to difficulty in the diagnosis of this disease. ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-405

    authors: Wang X,Yang W,Yang J

    更新日期:2010-08-04 00:00:00

  • Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.

    abstract:BACKGROUND:Prognostic factors aid in the stratification and treatment of cancer. This study evaluated prognostic importance of tumor infiltrating immune cell in patients with oral squamous cell carcinoma. METHODS:Profiles of infiltrating immune cells and clinicopathological data were available for 78 OSCC patients wit...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3317-2

    authors: Fang J,Li X,Ma D,Liu X,Chen Y,Wang Y,Lui VWY,Xia J,Cheng B,Wang Z

    更新日期:2017-05-26 00:00:00

  • Skin cancers in people with albinism in Togo in 2019: results of two rounds of national mobile skin care clinics.

    abstract:BACKGROUND:In people with albinism (PWA), the deficiency of melanin increase the risk of skin cancers. The aim of this study was to determine the prevalence of skin cancers and characteristics of these detected skin cancers (histological types, localization) in PWA in 10 cities in Togo in 2019. METHODS:This is a cross...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07747-8

    authors: Saka B,Akakpo SA,Teclessou JN,Gnossike P,Adam S,Mahamadou G,Kassang P,Elegbede Y,Mouhari-Toure A,Darre T,Kombate K,Pitché P

    更新日期:2021-01-05 00:00:00

  • Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.

    abstract:BACKGROUND:Pancreatic adenocarcinoma is one of the most dreaded cancers with very low survival rate and poor prognosis to the existing frontline chemotherapeutic drugs. Gene therapy in combination with a cytotoxic agent could be a promising approach to circumvent the limitations of previously attempted therapeutic inte...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-75

    authors: Xu J,Singh A,Amiji MM

    更新日期:2014-02-08 00:00:00

  • Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.

    abstract:BACKGROUND:More than 50% of metastatic melanoma patients have a specific mutation in the serine/threonine kinase BRAF. This results in constitutive activation of the RAS-RAF-MEK-ERK-MAP kinase pathway, which causes uncontrolled cell growth. Vemurafenib (PLX4032) is an oral chemotherapeutic agent that targets the specif...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4583-3

    authors: Xiao J,Egger ME,McMasters KM,Hao H

    更新日期:2018-06-22 00:00:00

  • Impact of diabetes type II and chronic inflammation on pancreatic cancer.

    abstract:BACKGROUND:We explored if known risk factors for pancreatic cancer such as type II diabetes and chronic inflammation, influence the pathophysiology of an established primary tumor in the pancreas and if administration of metformin has an impact on tumor growth. METHODS:Pancreatic carcinomas were assessed in a syngenei...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1047-x

    authors: Zechner D,Radecke T,Amme J,Bürtin F,Albert AC,Partecke LI,Vollmar B

    更新日期:2015-02-13 00:00:00

  • Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.

    abstract:BACKGROUND:Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose, hypofractionated radiotherapy, and achieves excellent rates of local control for primary tumors or metastases. A recent randomized phase II trial evalua...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-019-5977-6

    authors: Palma DA,Olson R,Harrow S,Correa RJM,Schneiders F,Haasbeek CJA,Rodrigues GB,Lock M,Yaremko BP,Bauman GS,Ahmad B,Schellenberg D,Liu M,Gaede S,Laba J,Mulroy L,Senthi S,Louie AV,Swaminath A,Chalmers A,Warner A,Slot

    更新日期:2019-08-19 00:00:00

  • Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.

    abstract:BACKGROUND:Annually, colorectal cancer (CRC) is diagnosed in >1.4 million subjects worldwide and incidence is increasing. Much effort has therefore been focused on screening, which has proven to reduce cancer-related mortality. The Sept9 DNA-methylation assay is among the most well studied blood-based screening markers...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1832-6

    authors: Ørntoft MB,Nielsen HJ,Ørntoft TF,Andersen CL,Danish Study Group on Early Detection of Colorectal Cancer.

    更新日期:2015-10-29 00:00:00

  • Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report.

    abstract:BACKGROUND:To the best of our knowledge, no study has reported mediastinal shift accompanied with obstructive atelectasis due to bulky primary esophageal tumor components treated with adaptive radiotherapy and concurrent chemotherapy. CASE PRESENTATION:Here we report the case of a 65-year-old male patient diagnosed wi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6505-4

    authors: Sakanaka K,Fujii K,Mizowaki T

    更新日期:2020-01-06 00:00:00

  • Favorable prognostic value of SOCS2 and IGF-I in breast cancer.

    abstract:BACKGROUND:Suppressor of cytokine signaling (SOCS) proteins comprise a protein family, which has initially been described as STAT induced inhibitors of the Jak/Stat pathway. Recent in vivo and in vitro studies suggest that SOCS proteins are also implicated in cancer. The STAT5 induced IGF-I acts as an endocrine and par...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-7-136

    authors: Haffner MC,Petridou B,Peyrat JP,Révillion F,Müller-Holzner E,Daxenbichler G,Marth C,Doppler W

    更新日期:2007-07-25 00:00:00

  • Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.

    abstract:BACKGROUND:Estrogen receptor (ER) expression is important for treatment selection and prognostication of breast cancer patients. Although the metastases are the main targets of endocrine therapy, ER status is often based on the primary tumor. However, ER expression in breast cancer primary lesion may not match with its...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5217-5

    authors: Zhao J,Hu C,Wang C,Yu W,Guo Y,Shi M,Shui Y,Wei Q

    更新日期:2018-12-27 00:00:00

  • Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.

    abstract:BACKGROUND:The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of accuracy in identifying HR patients with conventional risk factors (large, deep, ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07207-3

    authors: Filleron T,Le Guellec S,Chevreau C,Cabarrou B,Lesluyes T,Lodin S,Massoubre A,Mounier M,Poublanc M,Chibon F,Valentin T

    更新日期:2020-07-31 00:00:00

  • Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression.

    abstract:BACKGROUND:Abundant research suggested that the cancer cells avoid destruction by the immune system through down-regulation or mutation of death receptors. Therefore, it is very important that finding the agents that increase the death receptors of cancer cells. In this study, we demonstrated that the snake venom toxin...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-228

    authors: Park MH,Jo M,Won D,Song HS,Han SB,Song MJ,Hong JT

    更新日期:2012-06-08 00:00:00

  • Total and partial cancer prevalence in the adult French population in 2008.

    abstract:BACKGROUND:To provide estimations of partial and total prevalence of 24 cancer sites in France in 2008. The estimations of partial prevalence were compared with the previous estimations for 2002. METHODS:Nationwide estimations of incidence and survival data from cancer registries were used for partial prevalence. Nati...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1168-2

    authors: Colonna M,Mitton N,Bossard N,Belot A,Grosclaude P,French Network of Cancer Registries (FRANCIM).

    更新日期:2015-03-19 00:00:00

  • Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?

    abstract:BACKGROUND:The lymphocytes played an important role in the natural history of cancer. The aim of this study was to explore the prognostic value of lymphocyte count and percentage for survival in advanced cancer patients receiving palliative care. METHODS:A retrospective review of clinicopathological data from 378 cons...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3498-8

    authors: Zhao W,Wang P,Jia H,Chen M,Gu X,Liu M,Zhang Z,Cheng W,Wu Z

    更新日期:2017-08-02 00:00:00

  • Human endogenous retroviruses and cancer prevention: evidence and prospects.

    abstract:BACKGROUND:Cancer is a significant and growing problem worldwide. While this increase may, in part, be attributed to increasing longevity, improved case notifications and risk-enhancing lifestyle (such as smoking, diet and obesity), hygiene-related factors resulting in immuno-regulatory failure may also play a major ro...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-4

    authors: Cegolon L,Salata C,Weiderpass E,Vineis P,Palù G,Mastrangelo G

    更新日期:2013-01-03 00:00:00

  • Germline mutation in the RAD51B gene confers predisposition to breast cancer.

    abstract:BACKGROUND:Most currently known breast cancer predisposition genes play a role in DNA repair by homologous recombination. Recent studies conducted on RAD51 paralogs, involved in the same DNA repair pathway, have identified rare germline mutations conferring breast and/or ovarian cancer predisposition in the RAD51C, RAD...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-484

    authors: Golmard L,Caux-Moncoutier V,Davy G,Al Ageeli E,Poirot B,Tirapo C,Michaux D,Barbaroux C,d'Enghien CD,Nicolas A,Castéra L,Sastre-Garau X,Stern MH,Houdayer C,Stoppa-Lyonnet D

    更新日期:2013-10-19 00:00:00

  • Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.

    abstract:BACKGROUND:Oncolytic viruses, including vaccinia virus (VACV), are a promising alternative to classical mono-cancer treatment methods such as surgery, chemo- or radiotherapy. However, combined therapeutic modalities may be more effective than mono-therapies. In this study, we enhanced the effectiveness of oncolytic vir...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-366

    authors: Schäfer S,Weibel S,Donat U,Zhang Q,Aguilar RJ,Chen NG,Szalay AA

    更新日期:2012-08-23 00:00:00

  • Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.

    abstract:BACKGROUND:Mounting evidence shows that microRNA-34a (miR-34a) is involved in cancer prognosis. Therefore, we summarize the predictive role of miR-34a for survival in patients with gastrointestinal cancers (GICs). METHODS:All eligible studies were found by searching PubMed, Web of Science and EMBASE, and survival resu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07751-y

    authors: Chen YL,Liu XL,Li L

    更新日期:2021-01-14 00:00:00

  • Correction to: Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.

    abstract:CORRECTION:After publication of the original article [1] the authors found that the figure contained an incorrect version of Fig. 3a. This does not affect the results and conclusions of the article. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-017-3767-6

    authors: Wang X,Chen J,Wang J,Yu F,Zhao S,Zhang Y,Tang H,Peng Z

    更新日期:2018-01-11 00:00:00